Better Therapeutics, Inc. (BTTX)

Better Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	15.74	40.57	0.12	0.76
Cash & Short-Term Investments	15.74	40.57	0.12	0.76
Cash Growth	-61.20%	32880.49%	-83.75%	-
Other Receivables	0.05	0.28	0.22	-
Receivables	0.05	0.28	0.22	-
Prepaid Expenses	2.5	4.41	0.12	0.23
Other Current Assets	0.17	-	-	-
Total Current Assets	18.45	45.25	0.46	0.99
Property, Plant & Equipment	0.12	0.08	0.09	0.18
Other Intangible Assets	3.89	5.08	5.56	3.27
Other Long-Term Assets	0.49	0.55	0.28	0.44
Total Assets	22.94	50.96	6.39	4.88
Accounts Payable	3.04	1.52	0.51	0.34
Accrued Expenses	5.93	3.21	0.1	0.15
Current Portion of Long-Term Debt	4.53	-	-	-
Total Current Liabilities	13.49	4.73	0.61	0.49
Long-Term Debt	10.35	9.51	0.64	5
Long-Term Deferred Tax Liabilities	-	-	0.15	-
Other Long-Term Liabilities	-	-	11.74	-
Total Liabilities	23.84	14.24	13.15	5.49
Common Stock	0	0	0	0.21
Additional Paid-In Capital	110.6	108.46	24.65	-
Retained Earnings	-111.5	-71.74	-31.41	-25.02
Total Common Equity	-0.9	36.72	-6.76	-24.81
Shareholders' Equity	-0.9	36.72	-6.76	-0.61
Total Liabilities & Equity	22.94	50.96	6.39	4.88
Total Debt	14.88	9.51	0.64	5
Net Cash (Debt)	0.86	31.06	-0.52	-4.24
Net Cash Growth	-97.23%	-	-	-
Net Cash Per Share	0.04	2.39	-0.05	-0.89
Filing Date Shares Outstanding	23.85	23.61	5.7	4.74
Total Common Shares Outstanding	23.85	23.6	5.7	4.74
Working Capital	4.95	40.52	-0.15	0.5
Book Value Per Share	-0.04	1.56	-1.19	-5.23
Tangible Book Value	-4.79	31.64	-12.31	-28.08
Tangible Book Value Per Share	-0.20	1.34	-2.16	-5.92
Machinery	0.18	0.31	0.26	0.24
Leasehold Improvements	-	-	-	0.11

Updated Nov 9, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.